Phase III

You only have one chance to prepare for product launch. During this critical phase, focus is on achieving regulatory approval while enhancing the product’s commercial success and clinical relevance. We’ll add significant value to your product, working to maximize communication opportunities and strengthen the launch platform.

An integrated communications plan is vital to this success, combining an ongoing competitor assessment with your corporate product goals, the evolving supporting dataset, and the attitudes and knowledge of key stakeholder groups. Watermeadow has designed a number of unique elements for the planning process, maximizing communications effectiveness and focus, informing critical groups of actions and progress, and directing resources for greatest impact.

Using the literature and key meetings, we’ll co-ordinate the exposure of phase III data at strategically appropriate timepoints, ensuring the product is optimally supported throughout the launch period. International advisors will give critical input into positioning and we will help you to increase their roles through continuing involvement in the advocacy development program.

Let’s not forget internal communication. The goals during this period will be to prepare and motivate for the launch, ensuring that data and messages are accepted and understood, and later, that sales and marketing staff have the necessary product knowledge for customer communication. Combining our broad experience and innovative tools, we will initiate and enhance internal communications and maintain product awareness throughout your organization.